Anti-cancer drugs Flashcards

(26 cards)

1
Q

What is the mechanism of action of alkylating agents?

A

Insert alkyl group, usually a carbonium ion, that cross-links adjacent bases in DNA, particularly G, as well as proteins. This causes stress, breaking the strand and resulting in apoptosis. Cycle non-specific. Cross-linking between strands is more desirable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List four groups of classic cytotoxic agents.

A

Alkylating agents
Antimetabolites
Plant alkaloids
Hormonal agents antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List two types of novel anticancer agents.

A

Monoclonal antibodies

Immunomodulating agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List types of supportive therapy.

A

Analgesics, antidepressants, diet.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mechanism of action of antimetabolites?

A

Block DNA synthesis by substituting nucleotides. S phase inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List three targets of antimetabolites.

A

Folate, pyrimidine bases (C, T), purine bases (A, G)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the mechanism of action of plant alkaloids/mitotic poisons?

A

Inhibit either microtubule function or topoisomerase. M phase inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List two hormone modulators used in breast cancer.

A

SERMS and aromatase inhibitors (inhibit oestrogen release from adipocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List two hormone modulators used in prostate cancer.

A

Anti-androgens, gonadotrophin-RH analogues (reduce endogenous LH release )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which hormone modulators are used for blood-borne cancers?

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are common adverse effects of classic cytotoxic agents?

A

Alopecia, skin blistering and necrosis, GI sores (stomatitis) and mouth inflammation (mucositis), nausea and vomiting (chemo-trigger zone), infertility (particularly sperm), bone marrow suppression, organ toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which organs are affected by organ toxicity of classic cytotoxic agents?

A

Heart - dysrhythmia, altered contractility, acute-chronic heart failure
Nervous system - targeting microtubules affects axonal transport
Kidneys - renal failure
Urinary bladder - haemorrhagic cyctitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List three drug groups used to manage ADRs of classic cytotoxic drugs?

A

Antiemetic drugs
Colony stimulating factor (replenishing blood cells)
Organ toxicity drugs for haemorrhagic cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which antiemetic drugs are used in managing ADRs of classic cytotoxic agents?

A

Dopamine recetor antagonist (metoclopramide)
Serotonin receptor antagonist (ondansetron) - best
Neurokinin (substance p) receptor antagonist (aprepitant)
Glucocorticoids (dexamethasone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which colony stimulating factors are used in managing ADRs of classic cytotoxic agents?

A

Filigrastim (WBCs, particularly neutrophils)

Erythropoietin (RBCs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is mesna used in managing ADRs of classic cytotoxic agents?

A

When alkylating agents are used to reduce haemorrhagic cyctitis without affecting therapy.

17
Q

List 5 types of novel anti-cancer agents.

A

Monoclonal antibodies
Immunomodulating agents (biological response modifiers, cytokine treatment)
Inhibitors of intracellular signalling molecules (tyrosine kinase inhibitors, serine-threonine kinase inhibitors)
Sensitising agents

18
Q

List two monoclonal antibody drugs and their mechanism of action.

A

Rutiximab - anti-CD20 when over-expressed on B cells in non-Hodgkin’s lymphoma, triggering B cell lysis.

Trastuzumab (Herceptin) - binds to human epidermal growth factor 2 (HER2) when over-expressed in breast cancer

Attachment of cytotoxic agent to antibody

19
Q

List two biological response modifiers and their mechanism of action.

A

Interferons - augment the cytotoxicity of immune cells to inhibit proliferation and alter antigen expression of tumour and immune cells.

IL-2 - sensitise patient’s lymphocytes in-vitro as IL-2 stimulates lymphocyte proliferation and cellular immunity, not first-line

20
Q

What is the mechanism of action of inhibitor’s of intracellular signalling molecules?

A

Bind to kinase’s ATP site

Some also inhibit angiogenesis

21
Q

When are kinase inhibitors used?

A

Selected leukaemia and GI tumours

22
Q

Give an example of an immunisation using sensitising agents.

23
Q

List three complications of novel anti-cancer agents.

A

Drug resistance, tumour cell sanctuaries (tumour in inaccessible site), dose exhaustion.

24
Q

How can drug resistance be overcome?

A

Multiple cytotoxic drug therapy, drugs with different actions, drug holidays

25
How can tumour cell sanctuaries be overcome?
Radiotherapy, surgery
26
How can dose exhaustion be overcome?
Multiple drug therapy, radiotherapy, surgery, chemotherapy combination.